Jaguar Health's shares rose about 34% to $6.34 per share before Tuesday's market opened. The article gives no company update or reason for the move, so it does not change the business outlook.
A share-price jump alone does not show that Jaguar Health's sales, products, or finances changed. The story gives no reason for the move, so it adds no new information about the company's business.
Option Care Health's shares rose about 20% to $28.16 per share before Tuesday's market opened. The article gives no company update or reason for the move, so it does not change the business outlook.
QTREX Quantum's shares rose about 18% to $1.82 per share before Tuesday's market opened. The article gives no company update or reason for the move, so it does not change the business outlook.
Ernexa Therapeutics' shares rose about 11% to $3.00 per share before Tuesday's market opened. The article gives no company update or reason for the move, so it does not change the business outlook.
Cellectar Biosciences' shares rose about 11% to $1.85 per share before Tuesday's market opened. The article gives no company update or reason for the move, so it does not change the business outlook.
HeartSciences' shares fell about 16% to $3.64 per share before Tuesday's market opened. The article gives no company update or reason for the drop, so it does not change the business outlook.
Follow Jaguar Health (JAGX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for JAGX